1. Home
  2. INTT vs QNCX Comparison

INTT vs QNCX Comparison

Compare INTT & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo inTest Corporation

INTT

inTest Corporation

HOLD

Current Price

$10.77

Market Cap

139.2M

Sector

Technology

ML Signal

HOLD

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$29.48

Market Cap

17.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTT
QNCX
Founded
1981
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
139.2M
17.5M
IPO Year
1997
2019

Fundamental Metrics

Financial Performance
Metric
INTT
QNCX
Price
$10.77
$29.48
Analyst Decision
Strong Buy
Hold
Analyst Count
2
2
Target Price
$13.50
N/A
AVG Volume (30 Days)
97.6K
14.1K
Earning Date
05-05-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.06
N/A
Revenue
$66,801,000.00
N/A
Revenue This Year
$15.82
N/A
Revenue Next Year
$9.10
N/A
P/E Ratio
$177.33
N/A
Revenue Growth
66.06
N/A
52 Week Low
$7.07
$0.08
52 Week High
$20.00
$35.41

Technical Indicators

Market Signals
Indicator
INTT
QNCX
Relative Strength Index (RSI) 35.57 48.26
Support Level $10.32 $0.82
Resistance Level $10.88 $35.38
Average True Range (ATR) 0.48 2.14
MACD 0.04 -0.84
Stochastic Oscillator 7.28 34.79

Price Performance

Historical Comparison
INTT
QNCX

About INTT inTest Corporation

inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.

Share on Social Networks: